Bristol Myers Squibb Co director Julia A Haller sells $240,578 of BMY stock
An open-market sale on Nov 5, reported to the SEC on Nov 6, not marked as part of a 10b5-1 plan.
Julia A Haller, a director of Bristol Myers Squibb Co (BMY), sold 3,800 shares on Nov 5 at an average price of $63.31, a total of $240,578, according to a Form 4 filed with the SEC on Nov 6.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The sale reduces the insider's holding by 11%, to 30,279 shares.
The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Bristol Myers Squibb Co (BMY) |
|---|---|
| Insider | Julia A Haller |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 3,800 |
| Average price | $63.31 |
| Value | $240,578 |
| Trade date | Nov 5, 2026 |
| Filed with the SEC | Nov 6, 2026, 4:25 PM ET |
| Shares held after | 30,279 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
See earlier insider stories on Bristol Myers Squibb Co · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
